array:25 [
  "pii" => "S2013251416301304"
  "issn" => "20132514"
  "doi" => "10.1016/j.nefroe.2016.12.003"
  "estado" => "S300"
  "fechaPublicacion" => "2016-11-01"
  "aid" => "246"
  "copyright" => "Sociedad Española de Nefrología"
  "copyrightAnyo" => "2016"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Nefrologia (English Version). 2016;36:705"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2621
    "formatos" => array:3 [
      "EPUB" => 342
      "HTML" => 1792
      "PDF" => 487
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S0211699516301114"
      "issn" => "02116995"
      "doi" => "10.1016/j.nefro.2016.06.010"
      "estado" => "S300"
      "fechaPublicacion" => "2016-11-01"
      "aid" => "246"
      "copyright" => "Sociedad Española de Nefrología"
      "documento" => "simple-article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Nefrologia. 2016;36:705"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 3733
        "formatos" => array:3 [
          "EPUB" => 406
          "HTML" => 2530
          "PDF" => 797
        ]
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
        "titulo" => "Comment on &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "705"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Comentario a &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Erol Arslan, Adem Ayd&#305;n, &#350;eref Demirba&#351;, Kenan Sa&#287;lam"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Erol"
                "apellidos" => "Arslan"
              ]
              1 => array:2 [
                "nombre" => "Adem"
                "apellidos" => "Ayd&#305;n"
              ]
              2 => array:2 [
                "nombre" => "&#350;eref"
                "apellidos" => "Demirba&#351;"
              ]
              3 => array:2 [
                "nombre" => "Kenan"
                "apellidos" => "Sa&#287;lam"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2013251416301304"
          "doi" => "10.1016/j.nefroe.2016.12.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301114?idApp=UINPBA000064"
      "url" => "/02116995/0000003600000006/v1_201611240148/S0211699516301114/v1_201611240148/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S2013251417300135"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2017.01.010"
    "estado" => "S300"
    "fechaPublicacion" => "2016-11-01"
    "aid" => "248"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia &#40;English Version&#41;. 2016;36:706-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3899
      "formatos" => array:3 [
        "EPUB" => 363
        "HTML" => 2738
        "PDF" => 798
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Reply to letter to editor comment on &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "706"
          "paginaFinal" => "707"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Respuesta a la carta al editor referida a &#171;Mecanismos celulares y moleculares de la nefropat&#237;a diab&#233;tica&#44; rol del VEGF-A&#187;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Delma Veron, Alda Tufro"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Delma"
              "apellidos" => "Veron"
            ]
            1 => array:2 [
              "nombre" => "Alda"
              "apellidos" => "Tufro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0211699516301138"
        "doi" => "10.1016/j.nefro.2016.08.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301138?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300135?idApp=UINPBA000064"
    "url" => "/20132514/0000003600000006/v1_201702210030/S2013251417300135/v1_201702210030/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S201325141630133X"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2016.05.009"
    "estado" => "S300"
    "fechaPublicacion" => "2016-11-01"
    "aid" => "235"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Nefrologia &#40;English Version&#41;. 2016;36:701-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4655
      "formatos" => array:3 [
        "EPUB" => 314
        "HTML" => 3772
        "PDF" => 569
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Failed ABO incompatible high titers kidney transplant using bortezomib&#46; Case report"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "701"
          "paginaFinal" => "704"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Fracaso en el uso de bortezomib en el trasplante ABO incompatible con titulos altos&#46; Reporte de un caso"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1475
              "Ancho" => 2167
              "Tamanyo" => 206242
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Desensitization protocol&#44; including the three phases of consecutive treatment&#46; RTX&#44; rituximab&#59; BTZ&#44; bortezomib&#59; PE&#44; plasma exchange&#59; IVIG intravenous immunoglobulins&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Erika De Sousa-Amorim, Ignacio Revuelta, Fritz Diekmann, Joan Cid, Miquel Lozano, Federic Oppenheimer"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Erika"
              "apellidos" => "De Sousa-Amorim"
            ]
            1 => array:2 [
              "nombre" => "Ignacio"
              "apellidos" => "Revuelta"
            ]
            2 => array:2 [
              "nombre" => "Fritz"
              "apellidos" => "Diekmann"
            ]
            3 => array:2 [
              "nombre" => "Joan"
              "apellidos" => "Cid"
            ]
            4 => array:2 [
              "nombre" => "Miquel"
              "apellidos" => "Lozano"
            ]
            5 => array:2 [
              "nombre" => "Federic"
              "apellidos" => "Oppenheimer"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0211699516300868"
        "doi" => "10.1016/j.nefro.2016.05.022"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516300868?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141630133X?idApp=UINPBA000064"
    "url" => "/20132514/0000003600000006/v1_201702210030/S201325141630133X/v1_201702210030/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
    "titulo" => "Comment on &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "705"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Erol Arslan, Adem Ayd&#305;n, &#350;eref Demirba&#351;, Kenan Sa&#287;lam"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Erol"
            "apellidos" => "Arslan"
            "email" => array:1 [
              0 => "earslan89&#64;yahoo&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Adem"
            "apellidos" => "Ayd&#305;n"
          ]
          2 => array:2 [
            "nombre" => "&#350;eref"
            "apellidos" => "Demirba&#351;"
          ]
          3 => array:2 [
            "nombre" => "Kenan"
            "apellidos" => "Sa&#287;lam"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Department of Internal Medicine&#44; G&#252;lhane Military Medical Academy&#44; Ankara&#44; Turkey"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Comentario a &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read the published article with the title of &#8216;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8217;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> with a great interest and we found worth sharing our clinical observations through a case to contribute to the their determination&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Katherine Carranza et al&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> have stated that the experimental conditions VEGF-A decreased or after treatment with molecules developed against VEGF&#44; it can be observed various pathologic processes such as glomerular basement membrane damage&#44; proteinuria&#44; acute renal failure and thromboembolic events&#46; Monoclonal antibodies that bind the VEGF has long been used in systemic treatment protocol of solid tumors&#46; Recently&#44; by ophthalmologists&#44; intravitreal administration of anti-VEGF agents seen as the primary treatment method in conditions of age- related macular degeneration&#44; diabetic retinopathy&#44; retinal vein occlusion&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> Although systemic side effects are well known with the high dose intravenous use in cancer therapy&#44; almost local side effects were reported associated with intraocular anti-VEGF treatment&#46; However&#44; despite the blood retinal barrier&#44; anti-VEGF agents are detectable in systemic circulation after intraocular administration through uveal vessels or by aqueous humor outflow and might constitutes systemic adverse effect like nephropathy by antagonizing to VEGF-dependent pathway in glomeruli&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">We describe a case of nephrotic syndrome that were unable to detect significant findings for etiology in first research&#46; But with detailed history we found that she had received intravitreal anti-VEGF due to diabetic retinopathy 10 days before the occurrence of symptoms&#46; After the exclusion of other possible causes&#46; We thought anti-VEGF agents might be responsible&#46; In the literature&#44; we found only 3 cases associated with renal toxicity of intraocular anti-VEGF therapy&#46;<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">4&#8211;6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We would like to remind that even at the small quantities used in the practice of ophthalmology&#44; anti-VEGF agents may able to cause serious systemic effects including nephropathy&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46; Carranza"
                            1 => "D&#46; Veron"
                            2 => "A&#46; Cercado"
                            3 => "N&#46; Bautista"
                            4 => "W&#46; Pozo"
                            5 => "A&#46; Tufro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.nefro.2015.05.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia"
                        "fecha" => "2015"
                        "volumen" => "35"
                        "paginaInicial" => "131"
                        "paginaFinal" => "138"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26300505"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intravitreal bevacizumab &#40;Avastin&#41; treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;F&#46; Spaide"
                            1 => "Y&#46;L&#46; Fisher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Retina"
                        "fecha" => "2006"
                        "volumen" => "26"
                        "paginaInicial" => "275"
                        "paginaFinal" => "278"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16508426"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration&#58; a meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "W&#46; Wang"
                            1 => "X&#46; Zhang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0109744"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLOS ONE"
                        "fecha" => "2014"
                        "volumen" => "9"
                        "paginaInicial" => "e109744"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25330364"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relapse of minimal change nephrotic syndrome after intravitreal bevacizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Sato"
                            1 => "Y&#46; Kawasaki"
                            2 => "T&#46; Waragai"
                            3 => "T&#46; Imaizumi"
                            4 => "A&#46; Ono"
                            5 => "N&#46; Sakai"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ped.12017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Int"
                        "fecha" => "2013"
                        "volumen" => "55"
                        "paginaInicial" => "e46"
                        "paginaFinal" => "e48"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23782377"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Membranous nephropathy following intravitreal injection of bevacizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "H&#46;R&#46; Anto"
                            1 => "G&#46;F&#46; Hyman"
                            2 => "J&#46;P&#46; Li"
                            3 => "S&#46; Spitalewitz"
                            4 => "D&#46; Thomas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcjo.2011.12.024"
                      "Revista" => array:6 [
                        "tituloSerie" => "Can J Ophthalmol"
                        "fecha" => "2012"
                        "volumen" => "47"
                        "paginaInicial" => "84"
                        "paginaFinal" => "86"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22333861"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Pell&#233;"
                            1 => "N&#46; Shweke"
                            2 => "J&#46;P&#46; Duong Van Huyen"
                            3 => "L&#46; Tricot"
                            4 => "S&#46; Hessa&#239;ne"
                            5 => "V&#46; Fr&#233;meaux-Bacchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2010.11.030"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis"
                        "fecha" => "2011"
                        "volumen" => "57"
                        "paginaInicial" => "756"
                        "paginaFinal" => "759"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21295897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35436"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Comment on “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”
Comentario a “Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A”
Erol Arslan
Corresponding author
earslan89@yahoo.com

Corresponding author.
, Adem Aydın, Şeref Demirbaş, Kenan Sağlam
Department of Internal Medicine, Gülhane Military Medical Academy, Ankara, Turkey
Read
5573
Times
was read the article
1966
Total PDF
3607
Total HTML
Share statistics
 array:25 [
  "pii" => "S2013251416301304"
  "issn" => "20132514"
  "doi" => "10.1016/j.nefroe.2016.12.003"
  "estado" => "S300"
  "fechaPublicacion" => "2016-11-01"
  "aid" => "246"
  "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
  "copyrightAnyo" => "2016"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Nefrologia &#40;English Version&#41;. 2016;36:705"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2621
    "formatos" => array:3 [
      "EPUB" => 342
      "HTML" => 1792
      "PDF" => 487
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S0211699516301114"
      "issn" => "02116995"
      "doi" => "10.1016/j.nefro.2016.06.010"
      "estado" => "S300"
      "fechaPublicacion" => "2016-11-01"
      "aid" => "246"
      "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
      "documento" => "simple-article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Nefrologia. 2016;36:705"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 3733
        "formatos" => array:3 [
          "EPUB" => 406
          "HTML" => 2530
          "PDF" => 797
        ]
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
        "titulo" => "Comment on &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "705"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Comentario a &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Erol Arslan, Adem Ayd&#305;n, &#350;eref Demirba&#351;, Kenan Sa&#287;lam"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Erol"
                "apellidos" => "Arslan"
              ]
              1 => array:2 [
                "nombre" => "Adem"
                "apellidos" => "Ayd&#305;n"
              ]
              2 => array:2 [
                "nombre" => "&#350;eref"
                "apellidos" => "Demirba&#351;"
              ]
              3 => array:2 [
                "nombre" => "Kenan"
                "apellidos" => "Sa&#287;lam"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2013251416301304"
          "doi" => "10.1016/j.nefroe.2016.12.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301114?idApp=UINPBA000064"
      "url" => "/02116995/0000003600000006/v1_201611240148/S0211699516301114/v1_201611240148/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S2013251417300135"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2017.01.010"
    "estado" => "S300"
    "fechaPublicacion" => "2016-11-01"
    "aid" => "248"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia &#40;English Version&#41;. 2016;36:706-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3899
      "formatos" => array:3 [
        "EPUB" => 363
        "HTML" => 2738
        "PDF" => 798
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Reply to letter to editor comment on &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "706"
          "paginaFinal" => "707"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Respuesta a la carta al editor referida a &#171;Mecanismos celulares y moleculares de la nefropat&#237;a diab&#233;tica&#44; rol del VEGF-A&#187;"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Delma Veron, Alda Tufro"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Delma"
              "apellidos" => "Veron"
            ]
            1 => array:2 [
              "nombre" => "Alda"
              "apellidos" => "Tufro"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0211699516301138"
        "doi" => "10.1016/j.nefro.2016.08.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516301138?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417300135?idApp=UINPBA000064"
    "url" => "/20132514/0000003600000006/v1_201702210030/S2013251417300135/v1_201702210030/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S201325141630133X"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2016.05.009"
    "estado" => "S300"
    "fechaPublicacion" => "2016-11-01"
    "aid" => "235"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Nefrologia &#40;English Version&#41;. 2016;36:701-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4655
      "formatos" => array:3 [
        "EPUB" => 314
        "HTML" => 3772
        "PDF" => 569
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Failed ABO incompatible high titers kidney transplant using bortezomib&#46; Case report"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "701"
          "paginaFinal" => "704"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Fracaso en el uso de bortezomib en el trasplante ABO incompatible con titulos altos&#46; Reporte de un caso"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1475
              "Ancho" => 2167
              "Tamanyo" => 206242
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Desensitization protocol&#44; including the three phases of consecutive treatment&#46; RTX&#44; rituximab&#59; BTZ&#44; bortezomib&#59; PE&#44; plasma exchange&#59; IVIG intravenous immunoglobulins&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Erika De Sousa-Amorim, Ignacio Revuelta, Fritz Diekmann, Joan Cid, Miquel Lozano, Federic Oppenheimer"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Erika"
              "apellidos" => "De Sousa-Amorim"
            ]
            1 => array:2 [
              "nombre" => "Ignacio"
              "apellidos" => "Revuelta"
            ]
            2 => array:2 [
              "nombre" => "Fritz"
              "apellidos" => "Diekmann"
            ]
            3 => array:2 [
              "nombre" => "Joan"
              "apellidos" => "Cid"
            ]
            4 => array:2 [
              "nombre" => "Miquel"
              "apellidos" => "Lozano"
            ]
            5 => array:2 [
              "nombre" => "Federic"
              "apellidos" => "Oppenheimer"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0211699516300868"
        "doi" => "10.1016/j.nefro.2016.05.022"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699516300868?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141630133X?idApp=UINPBA000064"
    "url" => "/20132514/0000003600000006/v1_201702210030/S201325141630133X/v1_201702210030/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
    "titulo" => "Comment on &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "705"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Erol Arslan, Adem Ayd&#305;n, &#350;eref Demirba&#351;, Kenan Sa&#287;lam"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "Erol"
            "apellidos" => "Arslan"
            "email" => array:1 [
              0 => "earslan89&#64;yahoo&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Adem"
            "apellidos" => "Ayd&#305;n"
          ]
          2 => array:2 [
            "nombre" => "&#350;eref"
            "apellidos" => "Demirba&#351;"
          ]
          3 => array:2 [
            "nombre" => "Kenan"
            "apellidos" => "Sa&#287;lam"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Department of Internal Medicine&#44; G&#252;lhane Military Medical Academy&#44; Ankara&#44; Turkey"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Comentario a &#8220;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8221;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We read the published article with the title of &#8216;Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A&#8217;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> with a great interest and we found worth sharing our clinical observations through a case to contribute to the their determination&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Katherine Carranza et al&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">1</span></a> have stated that the experimental conditions VEGF-A decreased or after treatment with molecules developed against VEGF&#44; it can be observed various pathologic processes such as glomerular basement membrane damage&#44; proteinuria&#44; acute renal failure and thromboembolic events&#46; Monoclonal antibodies that bind the VEGF has long been used in systemic treatment protocol of solid tumors&#46; Recently&#44; by ophthalmologists&#44; intravitreal administration of anti-VEGF agents seen as the primary treatment method in conditions of age- related macular degeneration&#44; diabetic retinopathy&#44; retinal vein occlusion&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">2</span></a> Although systemic side effects are well known with the high dose intravenous use in cancer therapy&#44; almost local side effects were reported associated with intraocular anti-VEGF treatment&#46; However&#44; despite the blood retinal barrier&#44; anti-VEGF agents are detectable in systemic circulation after intraocular administration through uveal vessels or by aqueous humor outflow and might constitutes systemic adverse effect like nephropathy by antagonizing to VEGF-dependent pathway in glomeruli&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">We describe a case of nephrotic syndrome that were unable to detect significant findings for etiology in first research&#46; But with detailed history we found that she had received intravitreal anti-VEGF due to diabetic retinopathy 10 days before the occurrence of symptoms&#46; After the exclusion of other possible causes&#46; We thought anti-VEGF agents might be responsible&#46; In the literature&#44; we found only 3 cases associated with renal toxicity of intraocular anti-VEGF therapy&#46;<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">4&#8211;6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We would like to remind that even at the small quantities used in the practice of ophthalmology&#44; anti-VEGF agents may able to cause serious systemic effects including nephropathy&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cellular and molecular aspects of diabetic nephropathy&#59; the role of VEGF-A"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46; Carranza"
                            1 => "D&#46; Veron"
                            2 => "A&#46; Cercado"
                            3 => "N&#46; Bautista"
                            4 => "W&#46; Pozo"
                            5 => "A&#46; Tufro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.nefro.2015.05.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia"
                        "fecha" => "2015"
                        "volumen" => "35"
                        "paginaInicial" => "131"
                        "paginaFinal" => "138"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26300505"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intravitreal bevacizumab &#40;Avastin&#41; treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;F&#46; Spaide"
                            1 => "Y&#46;L&#46; Fisher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Retina"
                        "fecha" => "2006"
                        "volumen" => "26"
                        "paginaInicial" => "275"
                        "paginaFinal" => "278"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16508426"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration&#58; a meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "W&#46; Wang"
                            1 => "X&#46; Zhang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0109744"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLOS ONE"
                        "fecha" => "2014"
                        "volumen" => "9"
                        "paginaInicial" => "e109744"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25330364"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relapse of minimal change nephrotic syndrome after intravitreal bevacizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Sato"
                            1 => "Y&#46; Kawasaki"
                            2 => "T&#46; Waragai"
                            3 => "T&#46; Imaizumi"
                            4 => "A&#46; Ono"
                            5 => "N&#46; Sakai"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ped.12017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Int"
                        "fecha" => "2013"
                        "volumen" => "55"
                        "paginaInicial" => "e46"
                        "paginaFinal" => "e48"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23782377"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Membranous nephropathy following intravitreal injection of bevacizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "H&#46;R&#46; Anto"
                            1 => "G&#46;F&#46; Hyman"
                            2 => "J&#46;P&#46; Li"
                            3 => "S&#46; Spitalewitz"
                            4 => "D&#46; Thomas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jcjo.2011.12.024"
                      "Revista" => array:6 [
                        "tituloSerie" => "Can J Ophthalmol"
                        "fecha" => "2012"
                        "volumen" => "47"
                        "paginaInicial" => "84"
                        "paginaFinal" => "86"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22333861"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Pell&#233;"
                            1 => "N&#46; Shweke"
                            2 => "J&#46;P&#46; Duong Van Huyen"
                            3 => "L&#46; Tricot"
                            4 => "S&#46; Hessa&#239;ne"
                            5 => "V&#46; Fr&#233;meaux-Bacchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2010.11.030"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis"
                        "fecha" => "2011"
                        "volumen" => "57"
                        "paginaInicial" => "756"
                        "paginaFinal" => "759"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21295897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35436"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003600000006/v1_201702210030/S2013251416301304/v1_201702210030/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251416301304?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 2 1 3
2024 October 29 37 66
2024 September 39 22 61
2024 August 49 44 93
2024 July 37 19 56
2024 June 43 28 71
2024 May 45 23 68
2024 April 47 34 81
2024 March 27 22 49
2024 February 31 38 69
2024 January 25 24 49
2023 December 19 16 35
2023 November 31 25 56
2023 October 23 21 44
2023 September 23 27 50
2023 August 30 16 46
2023 July 29 25 54
2023 June 26 14 40
2023 May 37 22 59
2023 April 22 9 31
2023 March 36 28 64
2023 February 29 10 39
2023 January 17 16 33
2022 December 47 29 76
2022 November 34 29 63
2022 October 34 31 65
2022 September 37 26 63
2022 August 42 42 84
2022 July 22 34 56
2022 June 32 24 56
2022 May 29 28 57
2022 April 35 39 74
2022 March 42 38 80
2022 February 39 36 75
2022 January 28 31 59
2021 December 38 41 79
2021 November 29 32 61
2021 October 38 43 81
2021 September 41 32 73
2021 August 25 34 59
2021 July 34 23 57
2021 June 33 31 64
2021 May 29 31 60
2021 April 73 49 122
2021 March 38 30 68
2021 February 23 28 51
2021 January 33 16 49
2020 December 17 12 29
2020 November 35 14 49
2020 October 19 25 44
2020 September 19 15 34
2020 August 40 13 53
2020 July 18 17 35
2020 June 13 27 40
2020 May 30 20 50
2020 April 33 17 50
2020 March 23 16 39
2020 February 27 15 42
2020 January 37 24 61
2019 December 31 22 53
2019 November 27 20 47
2019 October 20 10 30
2019 September 25 16 41
2019 August 9 11 20
2019 July 16 27 43
2019 June 19 15 34
2019 May 21 10 31
2019 April 19 24 43
2019 March 27 16 43
2019 February 26 14 40
2019 January 20 15 35
2018 December 76 38 114
2018 November 140 17 157
2018 October 125 17 142
2018 September 63 10 73
2018 August 54 16 70
2018 July 62 16 78
2018 June 69 17 86
2018 May 69 14 83
2018 April 106 7 113
2018 March 95 8 103
2018 February 81 7 88
2018 January 90 8 98
2017 December 63 5 68
2017 November 49 14 63
2017 October 30 5 35
2017 September 37 10 47
2017 August 56 7 63
2017 July 46 8 54
2017 June 53 7 60
2017 May 44 9 53
2017 April 27 3 30
2017 March 25 4 29
2017 February 25 6 31
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?